METHOD, COMPOSITIONS AND KITS FOR INCREASING THE ORAL BIOAVAILABILITY OF PHARMACEUTICAL AGENTS
摘要
<p>A combination of 9,10-dihydro-5- methoxy-9-oxo-N- [4-[2-(1,2,3, 4-tetrahydro-6,7, -dimethoxy-2-isoquinolinyl) ethyl]phenyl]-4- acridinecarboxamide or a salt thereof and paclitaxel and its analogs or derivatives.</p>